<DOC>
	<DOCNO>NCT01190202</DOCNO>
	<brief_summary>The aim epidemiology study characterize standardized way malaria transmission intensity clinical trial center participate study 110021 ( NCT00866619 ) .</brief_summary>
	<brief_title>Epidemiology Study Malaria Transmission Intensity Africa</brief_title>
	<detailed_description>This study multicenter epidemiology study center participate GSK 's pivotal Phase III candidate malaria vaccine 110021 ( NCT00866619 ) trial involve 4 annual cross sectional survey perform preferably peak transmission . There study vaccine administer epidemiology study .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>Subjects investigator believe and/or parent ( ) /Legally Acceptable Representative ( ) comply requirement protocol . A male female 6 month old time survey . Written inform consent obtain subject/from parent ( ) / Legally Acceptable Representative ( ) subject . Child care . Previous current participation malaria vaccine trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
</DOC>